GPX4 and hepatocellular carcinoma: Experimental evidence demonstrates that knocking down either STMN1 or PRDX1 suppresses the expression of LDHA (a key enzyme for lactate metabolism) and GPX4 (a core regulator of ferroptosis), markedly reducing HCC cell malignant behaviors including proliferation, migratory capacity, and invasiveness.